Exparel 266 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FKKL1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,673
Award facts
- Contract value 100% obligated
- $25,673.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $25.7K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This delivery order, issued on January 13, 2026, with an ultimate completion date of February 4, 2026, operates under a firm fixed-price contract structure with no set-aside designation. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy designed to support pharmaceutical supply needs across the Department of Defense military healthcare system globally.
DMS Pharmaceutical Group's PPV-G GEN V prime vendor contract, valued at up to $499.999 billion with a completion date of December 31, 2036, authorizes the Defense Logistics Agency to issue delivery orders for a broad range of pharmaceuticals and medical consumables, including branded and generic prescription drugs, biologics, vaccines, and specialty surgical products. The company's established performance across numerous prior delivery orders, encompassing oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals, demonstrates its capability to fulfill the diverse specialized pharmaceutical requirements of military medical facilities. This current delivery order for EXPAREL, a specialty surgical product used for local anesthesia, reflects the company's continued role as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FKKL1?
SPE2DR26FKKL1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FKKL1 worth?
The government has obligated $25,673 on SPE2DR26FKKL1.
Is contract SPE2DR26FKKL1 an order under another contract?
Yes. SPE2DR26FKKL1 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKL1 competed?
The extent of competition for SPE2DR26FKKL1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award